Home|Journals|Articles by Year|Audio Abstracts
 

Review Article

IJMDC. 2020; 4(7): 1092-1096


Pharmacist-initiated medication error reporting and monitoring program

Khalid Sulaiman Masmali, Hussain Mohsen Maashi, Mohammed Ali Hussain Ayyashi, Ibrahim Mohammed Alnami, Abualqasim Abdullah Masmali, Sultan Ali MusaThubab.




Abstract

The use of the Medication Error Reporting and Monitoring Program (MERP) helps us to understand more about how and why medication errors (MEs) happen and has the potential to inform how we can improve the safety of medicinal use to prevent patient harm. The study aimed to review the studies discussing the pharmacist-initiated MERP and assess the most common medical errors and the causes of its incidence. PubMed was used for systematic search. The main search was carried out with the keywords: MERP and medical errors. The inclusion criteria included international studies, studies that were carried out in the kingdom, original articles, prospective and retrospective studies, cross‑sectional studies, and surveys. From the reviewed studies, MERP found that the frequent types of MEs were prescribing and improper dose/quantity. The most pharmacological classes of medication frequently involved with MEs were antibiotics, antihypertensive agents, and oral hypoglycemic agents. The most common reported causes of MEs were nonspecific performance deficit, knowledge deficit, and illegible or unclear handwriting. The study concludes that a clinical pharmacist initiated a nonpunitive anonymous ME reporting system that could improve the patient safety. Accurate medical error reporting is crucial for reducing the incidence of such errors and their adverse effects. Future studies needed to assess the impact of interventions to stimulate MEs reporting by the pharmacist in Saudi Arabia.

Key words: Pharmacist-initiated medication, error reporting, monitoring program






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.